24/7 Wall Street
28 Oct 2025, 18:21 UTC · 45w ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
Which stocks this story touches
Significant insider buying by the CEO and Director, coupled with positive clinical results for its lead drug candidate.
Large insider purchase by an institution and a price target increase by Wedbush based on strong Phase 3 trial results.
Aggressive insider buying by the Chairman and potential for its drug implant technology to transform obesity treatment.
Continue reading
5 related stories
Search tags
MarketBeat · 11h ago
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Proactive Investors
1d ago
